Riliprubart Biosimilar - Research Grade

Human

C1s

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2982

P09871

Blue ice

Complement component C1s is a serine protease that activates the classical complement pathway and is studied across autoimmune and neuroinflammatory disease research. This anti-human C1s recombinant monoclonal antibody is supplied as an unconjugated, non-therapeutic analog of riliprubart for research use only. Built to rigorous in vivo manufacturing standards with low endotoxin, it is produced in scalable milligram (mg) to gram (g) quantities suited to bulk and high-throughput laboratories. The reagent is appropriate for complement inhibition assays, in vitro functional screening, and in vivo models of complement-mediated disease, providing consistent, lot-to-lot reproducible performance.

EDSPD2, complement C1s

Detects human C1S

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks